Raspa Infertility Final(Optimized)

Embed Size (px)

Citation preview

  • 7/30/2019 Raspa Infertility Final(Optimized)

    1/49

  • 7/30/2019 Raspa Infertility Final(Optimized)

    2/49

    Objectives:

    List the common causes of male and female

    infertility

    Begin an infertility evaluation, ordering initialtests

    Prescribe simple treatments for infertile

    couples Facilitate appropriate referral to infertility

    specialists

  • 7/30/2019 Raspa Infertility Final(Optimized)

    3/49

    Infertility:

    Inability to conceive after 12 months of

    frequent, unprotected intercourse

    Some however begin initial work-up after 6months as the fecundability (ability to

    conceive) decreases as times passes,

    particularly if history suggests infertility or if

    female partner older than 35 (decreased

    ovarian function)

  • 7/30/2019 Raspa Infertility Final(Optimized)

    4/49

    Is infertility common?

    10-15% of couples in the US

    1.2 million women visited their primary caredoctor for infertility in 2002

  • 7/30/2019 Raspa Infertility Final(Optimized)

    5/49

    Risk Factors

    Smokingdecreased conception

    Alcoholincreased infertility

    Stress (acupuncture helps)

    IUD removaltakes longer to conceive

    Increased agefathers over 40

    Gulf war vets

    Inflammatory bowel disease

  • 7/30/2019 Raspa Infertility Final(Optimized)

    6/49

    Other Factors

    No increased risk with male underwear type

    or

    Ruptured appendix Unknown effects of environmental

    estrogensPCBs

    Nifedipine may decrease male fertility?

  • 7/30/2019 Raspa Infertility Final(Optimized)

    7/49

    Timing Factors

    Sperm live 48-72 hours

    Eggs live 12 hours

    Fertility Focused Intercourse is important

  • 7/30/2019 Raspa Infertility Final(Optimized)

    8/49

    Etiology:

    Male: 20%

    Female: 38%

    Mixed: 27%

    Unexplained: 15%

    Importance of evaluation of both partners

    WHO 1982-1985 multi-center study

  • 7/30/2019 Raspa Infertility Final(Optimized)

    9/49

    Causes of Female Infertility

    Ovulation disorders-25%

    Endometriosis-25%

    Pelvic Adhesions-12%

    Tubal Blockage-11%

    Other Tubal Factors-11%

    Hyperprolactinemia-7%WHO Technical Report Series 1992

  • 7/30/2019 Raspa Infertility Final(Optimized)

    10/49

    Female Causes:

    Cervical factorsbad mucus, antibodies, infection

    Uterine Factorssubmucosal fibroids, bicornuate

    uterus, Ashermans syndrome

    Tubal factorsPID, endometriosis, post-op

    adhesions

    Ovary Factorsanovulation, luteal phase defect,

    toxins (chemotherapy) Bad eggschromosomal (Turners Syndrome)

  • 7/30/2019 Raspa Infertility Final(Optimized)

    11/49

    Female H&P:

    Gs and Ps

    PMH including STD Hx

    Medications

    Substance Use Menstrual Hx

    Age at onset? Regular? Duration? Premenstral Sx?

    Endometriosis Sx: dysmenorrhea, dyspareunia,

    Endocrine Sx: galactorrhea, hirsuitism, fatigue,constipation, weight gain, etc

    Exercise

  • 7/30/2019 Raspa Infertility Final(Optimized)

    12/49

    Female H&P:

    Physical Exam:

    Vitals, BMI

    Skin: Acne, hirsuitism

    Thyroid: enlargement

    Breast: galactorrhea, development

    Pelvic: uterine size, tenderness, discharge,

    masses, development

  • 7/30/2019 Raspa Infertility Final(Optimized)

    13/49

    Initial Counseling:

    Frequency and timing of intercourse

    Fertile Interval: 5 days preceding ovulation and day of

    ovulation

    Smoking Alcohol

    Caffeine

    Stress Body weight (Ideal BMI is 20-25)

    Prenatal vitamins

  • 7/30/2019 Raspa Infertility Final(Optimized)

    14/49

    Initial Female Work-Up:

    Ovulation???:

    Regular Menses with Premenstrual Sx:

    Some confirm ovulation by history/chartingalone

    Irregular Menses or desire confirmation:

    Charting

    Progesterone on cycle day 21

    LH surge (home urinary kits)

  • 7/30/2019 Raspa Infertility Final(Optimized)

    15/49

    Charting:

  • 7/30/2019 Raspa Infertility Final(Optimized)

    16/49

    Menstrual Cycle:

  • 7/30/2019 Raspa Infertility Final(Optimized)

    17/49

    Ovulation Disorders:

    WHO Classification:

    1: Hypogonadotropic Hypogonadal

    5-10%

    2: Normogonadotropic Normoestrogenic

    70-85%

    Includes PCOS

    3: Hypergonadotropic Hypoestrogenic 10-30%

    Hyperprolactinemia

  • 7/30/2019 Raspa Infertility Final(Optimized)

    18/49

    Anovulation:

    Determination of cause/class:

    FSH/LH

    Estradiol (E2)

    Progesterone

    Prolactin/TSH

    Comprehensive Metabolic Panelliver, renal

    Testosterone, Androstenedione, DHEA-S,

    17-OH Progesterone

  • 7/30/2019 Raspa Infertility Final(Optimized)

    19/49

    Class 1 Anovulation:

    Hypogonadotropic Hypogonadal Low FSH and low estradiol

    Due to either decreased hypothalamic secretion

    of GnRH (Kallmans) or pituitary insensitivity toGnRH

    Results in decreased pituitary release of FSH

    FSH stimulates follicular maturation and thus

    estradiol secretion

  • 7/30/2019 Raspa Infertility Final(Optimized)

    20/49

    Class 1 Treatment:

    Gonadotropins (FSH/LH)

    Indications:

    Class 1 anovulatory pts Class 2 anovulatory pts who have failed initial tx

    Risks:

    Multiple gestations Ovarian hyperstimulation

  • 7/30/2019 Raspa Infertility Final(Optimized)

    21/49

    Class 1 Treatment:

    Gonadotropins (FSH/LH)

    Dose:

    Step-up vs Step-down protocols Monitoring:

    Transvaginal US q2-3 days to monitor follicles

    and timing of hCG dose to induce ovulation of

    dominant follicle

    Given by Reproductive Endocrinologists

  • 7/30/2019 Raspa Infertility Final(Optimized)

    22/49

    Class 2 Anovulation:

    Normogonadotropic Normoestrogenic:

    Normal levels of FSH and estrodiol

    FSH secretion during follicular phase is sub-

    normal

    May ovulate intermittently, particularly if have

    oligomenorrhea

    Causes: PCOS, Hyperthyroidism, Androgenichormones from tumors, liver or renal disease,

    Cushings (work-up is here)

  • 7/30/2019 Raspa Infertility Final(Optimized)

    23/49

    Treatment of Class 2 Anovulation:

    Check lab results from anovulatory work upand treat as appropriate

    PCOS: increased BMI, hirsuitism, anovulation,

    2:1 LH:FSH ratio Best treatment is achieve ideal body weight

    or at least a 10% reduction in wt.

    Best BMI 20-25 Low body wt or high stress decreases

    GnRH, can be like WHO 1 .

  • 7/30/2019 Raspa Infertility Final(Optimized)

    24/49

    Class 2 Treatment: Metformin

    Improves insulin insensitiviy

    Restores ovulation in 50% of PCOS

    Titrate dose to minimize side effects

    Minimal effect on hirsuitism Trial for 6 months with continued charting to eval

    for ovulation

    Not FDA approved for combo with Clomiphene butsome trials have shown benefit of combo whileothers show similar success rates as Clomiphenealonecombined effect 60% preg rate in PCOS

  • 7/30/2019 Raspa Infertility Final(Optimized)

    25/49

    Class 2 Treatment: Clomiphene

    Induces ovulation by increased gonadotropinrelease

    Dose: 50mg days 5-9; up to 100mg daily if needed

    Intercourse timing and frequency; +/- urine LH kit +/- Metformin (PCOS)

    +/- Intrauterine Insemination (cervical factors)

    6 cycles max

    Letrazole is alternative with similar efficacy to

    Clomiphene

  • 7/30/2019 Raspa Infertility Final(Optimized)

    26/49

    Class 2 Treatment: Aromatase

    Inhibitors Block final step of estrogen synthesis

    Letrozol 2.5 - 5mg daily on days 3-7

    (anastazol) or 25mg once day 3.

    Intercourse timing and frequency; +/- urineLH kit

    Similar efficacy to clomiphene

    Minimal side effects

    Lower incidence of multiple gestations

  • 7/30/2019 Raspa Infertility Final(Optimized)

    27/49

    Class 3 Anovulation:

    Hypergonadotropic Hypoestrogenic:

    High FSH and low estradiol

    FSH is inappropriately high due to lack of

    negative feedback from estradiol

    Causes: Premature ovarian failure or Ovarian

    resistance

    Resistant to treatment

  • 7/30/2019 Raspa Infertility Final(Optimized)

    28/49

    Class 3 Anovulation:

    Rare

    Poor Prognosis--best test is Antimullerian

    Hormonehigh is good, less than 2.5 is bad Clue given with Clomiphene Challenge Test

    Test FSH on Day 3

    Clomiphene Day 5-9 Test FSH on Day 10

    If either FSH greater than 10, reduced ovarian

    function.

  • 7/30/2019 Raspa Infertility Final(Optimized)

    29/49

    Anovulatory Treatment Overview:

    WHO Class 1: GnRH problemtreat with

    GnRH pump and support (Not available in

    US) or Gonadotropins (Refer)

    WHO Class 2: Most patients herewe can

    treat

    WHO Class 3: Ovarian failurelittle hope

    with any therapy (Refer)

    Hyperprolactinemia: RxDrugs or Surgery

  • 7/30/2019 Raspa Infertility Final(Optimized)

    30/49

    Regular Menses:

    Ovulatory cycles confirmed by:

    Charting x 3 months

    Cycle day 21 Progesterone

    LH surge

    Fertility focused intercourse

  • 7/30/2019 Raspa Infertility Final(Optimized)

    31/49

    Ovulation confirmed:

    Lifestyle changes

    Chlamydia/GC test

    Male partner testing

    Good Cervical Mucus Mucus enhancermucinex, vit B6

    Increase mucus with antibiotics day 9-14

    Prolactin, TSH

    Luteal phase defect? < 10 days

    Fertility focused intercourse x 3 months

  • 7/30/2019 Raspa Infertility Final(Optimized)

    32/49

    Further work-up:

    Check Hysterosalpingogram (HSG)

    Tubal factors: patency

    Uterine factors: anatomy, submucosal fibroids

    Oil based contrast has a good track record ofpregnancy after HSG

    If 3 more months go by will need laparoscopy to

    check for endometriosis, adhesions, ovarianproblems (hydrosalpinges)

    Key to treatment is find the problem and treat

  • 7/30/2019 Raspa Infertility Final(Optimized)

    33/49

    Male Infertility

    Male factor infertility 20% of couples

    Contributes to 30-40%

    Azoospermiano sperm

    Aspermiano semen

    Oligospermiadecreased normal sperm

    Need 2 sperm samples after 48-72 hourabstinence say experts

    AUA and ASRM Practice Committee Reports2001

  • 7/30/2019 Raspa Infertility Final(Optimized)

    34/49

    Male Infertility

    Pre-testicularendocrinetreatablerare

    Testicularspermatogenesisuntreatableexcept varicoceles

    Post-testicular40% obstruction

    History

    Mumps, Trauma, Infection, Chemo, Radiation,

    HeatUnderwear doesnt matter Family History?

    Prior Fertility?

  • 7/30/2019 Raspa Infertility Final(Optimized)

    35/49

    Male Workup

    Exam

    Male secondary sex characteristics

    Assure vas deferens bilaterally

    Testis size

    Varicocele

  • 7/30/2019 Raspa Infertility Final(Optimized)

    36/49

    Sperm Count

    FertileOver 48 million, Over 63% motile,

    Over 12% normal morphology

    Likely Not FertileLess than 13.5

    million,Less than 32% motile, Less than 9%

    normal morphology

    In the middleindeterminateNew England J Med 2001:345:1388

  • 7/30/2019 Raspa Infertility Final(Optimized)

    37/49

    Lab Workup

    Abnormal semen--

  • 7/30/2019 Raspa Infertility Final(Optimized)

    38/49

    Male Causes

    Absense of vas deferens

    Renal agenesis in 10-20%

    Cystic Fibrosismost will have congenital

    bilateral absence of vas deferens

    CFTR mutationif positive, check female

    Bilateral testicular atrophy

    Low FSH and TKallman or Pituitary tumor

    Check prolactin and MRI

  • 7/30/2019 Raspa Infertility Final(Optimized)

    39/49

    Duct Obstruction

    May be treatable

    If normal volumeeither disordered

    spermatogenesis or near testicular

    obstruction

    If FSH upspermatogenesis problem

    If FSH is normal, biopsy testis

    Low sperm volumeejaculatory dysfunction

    Consider TRUS

  • 7/30/2019 Raspa Infertility Final(Optimized)

    40/49

    Azoospermia

    Check chromosome7% abnormal

    2/3 Klinefelters XXY

    Microdeletions on Y chromosome seen with

    PCR, not on karyotype

    Assay when non-obstructive oligospermia with

    sperm less than 5 million

  • 7/30/2019 Raspa Infertility Final(Optimized)

    41/49

    Unexplained Infertility

    Most likely combined male and female

    factors

    Treatments are multiple but many

    unsatisfying

    Time alone may be treatment or

    Refer

  • 7/30/2019 Raspa Infertility Final(Optimized)

    42/49

    Advanced Reproductive

    Technologies (ART)

    Most deliver normal infants

    BUT: Infertility treatment associated with

    increased risk of adverse pregnancy

    outcomes

    Placental abruption, fetal loss 2nd trimester,

    preeclampsia, previa, C/S, ovarian torsion

  • 7/30/2019 Raspa Infertility Final(Optimized)

    43/49

    Advanced Reproductive

    Technologies (ART)

    Multiple births and birth defects, preterm

    and low birth weight, cerebral palsey

    Insufficient evidence regarding risks and

    benefits for IVF for unexplained infertility

    18-22% success per cycle

  • 7/30/2019 Raspa Infertility Final(Optimized)

    44/49

    Other Drugs

    Metformin may induce ovulation inanovulatory women withouthyperandrogenism

    ASA doesnt help Testosterone doesnt help for males

    Ginseng may help increase sperm count

    and motility Chasteberry associated with increased

    pregnancy ratelevel 2 evidence

  • 7/30/2019 Raspa Infertility Final(Optimized)

    45/49

    Other considerations

    Intrauterine insemination (IUI) better if

    antibodies or if subfertile male

    As effective, cheaper, and safer than IVF for

    idiopathic infertilityLancet 2000

    Varicocele repair probably doesnt help

    FSH (HCG) therapy for subfertilitymixedresults

  • 7/30/2019 Raspa Infertility Final(Optimized)

    46/49

    Pregnancy Support:

    After conception progesterone

    supplementation has been shown to be

    effective in reducing miscarriage,

    preeclampsia and preterm birthin IVF andwithout

    Can use HCG as wellstimulates estrogen

    and progesterone

  • 7/30/2019 Raspa Infertility Final(Optimized)

    47/49

    Pregnancy Support:

    Counselinggroupimproved pregnancy

    rate

    Accupuncture works for IVFlikely works

    for normal conception if stress is an issue

  • 7/30/2019 Raspa Infertility Final(Optimized)

    48/49

    Summary:

    Consider causes of infertility

    Do systematic workupovulatory vs non-

    ovulatory

    If ovulatory, consider tubal and male factors

    Find the cause and treat.

    Refer when unable to find cause or if unableto perform treatment

  • 7/30/2019 Raspa Infertility Final(Optimized)

    49/49

    Questions?